Stephen Taub

Latest Articles

biopharma and stock market gains

For Members Only

Biopharma Continues to Buoy the IPO Market

Stephen Taub September 28, 2026

cutting wins, taking profits

For Members Only

Seligman Cuts AI Exposure, Preserving a Nearly 40 Percent Gain

Stephen Taub September 24, 2026

AI and drug development medicines

For Members Only

AI Drug Discovery Reaches the IPO Market

Stephen Taub September 23, 2026

Silicon Valley

These Hedgies Invested in the Latest Unicorns

Stephen Taub September 22, 2026

surge

For Members Only

Mulvaney, Quantedge Lead Surging CTAs

Stephen Taub September 21, 2026

robotics

Tiger Global’s Robotics Strategy

Stephen Taub September 17, 2026

biopharma

Hedge Funds Look for Rare IPO to Extend Biopharma Rally

Stephen Taub September 16, 2026

markets

For Members Only

Long-Only Funds Lead Tigers in August

Stephen Taub September 15, 2026

hospital

For Members Only

Biopharma Hedge Funds Gain as Dealmaking Accelerates

Stephen Taub September 14, 2026

legal

For Members Only

Whale Rock Makes Rare VC Bet on Harvey at $15.5B Embrace AI Unicorn

Stephen Taub September 10, 2026

revealing a card hand

For Members Only

Third Point Posts Loss — And Reveals Four New Bets That Become Top Holdings

Stephen Taub September 9, 2026

rollercoaster wild ride

For Members Only

Haidar Jupiter Turns a Seemingly Disastrous Year Positive

Stephen Taub September 8, 2026

meds

For Members Only

RA Capital Management, Janus Henderson, Balyasny Back Reverse Merger of Biotech Company

Stephen Taub September 3, 2026

vinyl

For Members Only

Coatue Makes Third Bet on AI Startup in Music and Entertainment

Stephen Taub September 2, 2026

losses

Greenlight’s August Loss Cuts Into Strong Year-to-Date Return

Stephen Taub September 1, 2026

AI Mania Boosts These Hedgies

Stephen Taub August 31, 2026

Valiant’s Chris Hansen Bullish on AI Spending

Stephen Taub August 27, 2026

robotics

For Members Only

Tiger Global Emerges as Major Hedge Fund Player in Robotics SPAC Deal

Stephen Taub August 26, 2026

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.29.00 build:2026-09-28 Login